Firstly, in contrast to these two NUP214 translocations the ABL1 fusion molecules are involved in intracellular signaling, and the ABL1-NUP214 AML variants are probably heterogeneous with regard to genetics/leukemogenesis/chemosensitivity (see Section 7). The gene discussed is ABL1; the disease is acute myeloid leukemia.